Omicron's message on vaccines: Boosting begets breadth.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35065712.
- Also identified by DOI 10.1016/j.cell.2022.01.006 and PMC identifier 8758338.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue of Cell, three studies confirm that SARS-CoV-2 Omicron strongly evades a key immune defense-neutralizing antibodies. However, while one- or two-dose vaccine regimens fail to induce anti-Omicron neutralizing antibodies, a homologous third-dose booster rescues neutralization function in a way that highlights the adaptability of immune memory, where recalled immunity extends antibody reach across SARS-CoV-2 variants.
Medical subject headings
- COVID-19
- Vaccines